KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Gains from Investment Securities (2018 - 2025)

Castle Biosciences (CSTL) has disclosed Gains from Investment Securities for 8 consecutive years, with -$4.2 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 1468.52% to -$4.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $115000.0 through Dec 2025, up 18.56% year-over-year, with the annual reading at $115000.0 for FY2025, 18.56% up from the prior year.
  • Gains from Investment Securities hit -$4.2 million in Q4 2025 for Castle Biosciences, down from $1.2 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $18.1 million in Q4 2022 to a low of -$20.4 million in Q2 2022.
  • Historically, Gains from Investment Securities has averaged -$42285.7 across 5 years, with a median of $34000.0 in 2022.
  • Biggest five-year swings in Gains from Investment Securities: surged 2247.62% in 2021 and later tumbled 1468.52% in 2025.
  • Year by year, Gains from Investment Securities stood at $2.5 million in 2021, then surged by 634.65% to $18.1 million in 2022, then crashed by 106.26% to -$1.1 million in 2023, then surged by 126.9% to $305000.0 in 2024, then crashed by 1468.52% to -$4.2 million in 2025.
  • Business Quant data shows Gains from Investment Securities for CSTL at -$4.2 million in Q4 2025, $1.2 million in Q3 2025, and $3.1 million in Q2 2025.